Long-acting reversible contraceptives (LARCs) are significantly more effective than oral contraceptive pills, rings, or patches in preventing unintended pregnancy in adolescent girls and young women, a large prospective cohort study from Washington University School of Medicine reports.
Long-acting reversible contraceptives (LARCs) are significantly more effective than oral contraceptive pills, rings, or patches in preventing unintended pregnancy in adolescent girls and young women, a large prospective cohort study from Washington University School of Medicine (St. Louis, Missouri) reports.
Because more than half of all unplanned pregnancies in the United States are related to inconsistent or incorrect use of contraceptives, the 4-year study focused on identifying whether LARCs (intrauterine devices [IUDs] or implants) could be more effective than other commonly prescribed forms of contraception-pills, patches, rings, and injections-in preventing contraceptive failure.
More than 9,000 sexually active participants between the ages of 14 and 45 who weren't currently using a contraceptive method and who wanted to avoid pregnancy for at least a year were provided with counseling about reversible contraception and were offered free reversible contraception for 3 years (5,090 participants) or 2 years (4,166 participants). All had the opportunity to change or discontinue methods throughout the follow-up period. They were interviewed about demographics, sexual history, missed menses, and sexual activity at enrollment, at 3 and 6 months, and at 6-month intervals thereafter. A total of 7,486 women met the study criteria.
Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. New Engl J Med. 2012;366(21):1998-2007.
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More
Barriers in seeking pelvic floor disorder treatment among ethnic minorities
May 8th 2024A recent shed light on how ethnic minority groups perceive pelvic floor disorders, highlighting barriers to treatment seeking and the importance of raising awareness about available treatment options.
Read More
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More